Home
ISPO
ISPO News

Latest Inspirato Incorporated (ISPO) News on July 27, 2024

Inspirato First Quarter 2024 Earnings: EPS: US$0.19 (vs US$0.90 loss in 1Q 2023)

Simply Wall St.

3 months ago

Inspirato First Quarter 2024 Earnings: EPS: US$0.19 (vs US$0.90 loss in 1Q 2023)

Inspirato Announces First Quarter 2024 Results; Improved Occupancy Rates Contribute to Margin Expansion and Quarterly Profits

GlobeNewswire

3 months ago

Inspirato Announces First Quarter 2024 Results; Improved Occupancy Rates Contribute to Margin Expansion and Quarterly Profits

Inspirato to Announce First Quarter 2024 Results Tuesday, May 7

GlobeNewswire

3 months ago

Inspirato to Announce First Quarter 2024 Results Tuesday, May 7

flyExclusive Announces Partnership with Inspirato

Business Wire

4 months ago

flyExclusive Announces Partnership with Inspirato

Will Inspirato (NASDAQ:ISPO) Spend Its Cash Wisely?

Simply Wall St.

5 months ago

Will Inspirato (NASDAQ:ISPO) Spend Its Cash Wisely?

Inspirato Announces 2023 Revenue and Adjusted EBITDA within Previously Guided Ranges, Provides 2024 Guidance

GlobeNewswire

5 months ago

Inspirato Announces 2023 Revenue and Adjusted EBITDA within Previously Guided Ranges, Provides 2024 Guidance

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 02/21/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 02/20/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 02/16/2024

Inspirato to Announce Fourth Quarter and Full Year 2023 Results Tuesday, March 5

GlobeNewswire

5 months ago

Inspirato to Announce Fourth Quarter and Full Year 2023 Results Tuesday, March 5

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 02/14/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 02/13/2024

Argus Research

5 months ago

Daily – Vickers Top Insider Picks for 02/12/2024

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 02/09/2024

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 02/08/2024

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 02/07/2024

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 02/06/2024

Argus Research

6 months ago

Daily – Vickers Top Insider Picks for 02/05/2024

Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers

GlobeNewswire

6 months ago

Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers

Business Wire

6 months ago

Harte Hanks Strengthens Senior Leadership Team

Reuters

6 months ago

GLOBAL MARKETS-Asia stocks eye weekly gain; US inflation data looms

Isabeau Levito edges Amber Glenn in figure skating nationals short program

NBC Sports

6 months ago

Isabeau Levito edges Amber Glenn in figure skating nationals short program

Splash Beverage Group's Copa di Vino Now Available in Save Mart Stores Throughout California

NewMediaWire

6 months ago

Splash Beverage Group's Copa di Vino Now Available in Save Mart Stores Throughout California

Aspira Women’s Health Announces $5.5 Million Registered Direct Offering and Concurrent Private Placement

GlobeNewswire

6 months ago

Aspira Women’s Health Announces $5.5 Million Registered Direct Offering and Concurrent Private Placement

Here's Why Harte Hanks (NASDAQ:HHS) Has Caught The Eye Of Investors

Simply Wall St.

6 months ago

Here's Why Harte Hanks (NASDAQ:HHS) Has Caught The Eye Of Investors

Canoo: Buy, Sell, or Hold?

Motley Fool

6 months ago

Canoo: Buy, Sell, or Hold?

Zacks Small Cap Research

6 months ago

CTSO: CytoSorbents reports update on data results from important U.S. and Canadian STAR-T pivotal trial.

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01

GlobeNewswire

6 months ago

Perspective Commences Recruitment for Second Dose Escalation Cohorts in Clinical Studies of Two Lead Programs: [(212)Pb]VMT-α-NET and [(212)Pb]VMT01

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

GlobeNewswire

6 months ago

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

6 months ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

Market Exclusive

7 months ago

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Urban Farming Frontiers: 3 Stocks Growing Greens in the City

InvestorPlace

7 months ago

Urban Farming Frontiers: 3 Stocks Growing Greens in the City

Powered By Nvidia, Beamr (NASDAQ:BMR) Aims To Disrupt The Video World

ACCESSWIRE

7 months ago

Powered By Nvidia, Beamr (NASDAQ:BMR) Aims To Disrupt The Video World

bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

ACCESSWIRE

7 months ago

bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

Volition Issues Business Review 2023

PR Newswire

7 months ago

Volition Issues Business Review 2023

Harte Hanks Extends Line of Credit with Texas Capital Bank

ACCESSWIRE

7 months ago

Harte Hanks Extends Line of Credit with Texas Capital Bank

Blue Hat Announces Financial Results for the First Half of 2023, Highlighted by 5,657.93% Increase in Revenues to $46.30 million

GlobeNewswire

7 months ago

Blue Hat Announces Financial Results for the First Half of 2023, Highlighted by 5,657.93% Increase in Revenues to $46.30 million

Nike downgraded, Waste Management upgraded: Wall Street's top analyst calls

The Fly

7 months ago

Nike downgraded, Waste Management upgraded: Wall Street's top analyst calls

ZeroFox Achieves Outstanding Recognition in G2's Winter 2024 Report, Securing Multiple Badges in Key Cybersecurity Categories

GlobeNewswire

7 months ago

ZeroFox Achieves Outstanding Recognition in G2's Winter 2024 Report, Securing Multiple Badges in Key Cybersecurity Categories

7 Stocks to Buy if You’re Bullish on the Energy Sector

InvestorPlace

7 months ago

7 Stocks to Buy if You’re Bullish on the Energy Sector

Investing in Summit State Bank (NASDAQ:SSBI) three years ago would have delivered you a 38% gain

Simply Wall St.

7 months ago

Investing in Summit State Bank (NASDAQ:SSBI) three years ago would have delivered you a 38% gain

ArrowMark Financial Corp. Announces Special Distribution of $0.10 and Regular Cash Distribution of $0.45 per Share for the Fourth Quarter 2023

GlobeNewswire

8 months ago

ArrowMark Financial Corp. Announces Special Distribution of $0.10 and Regular Cash Distribution of $0.45 per Share for the Fourth Quarter 2023

Phoenix Motorcars and Rayz Technologies Establish Cooperation for Autonomous Driving Vehicles with LiDAR

ACCESSWIRE

8 months ago

Phoenix Motorcars and Rayz Technologies Establish Cooperation for Autonomous Driving Vehicles with LiDAR

noco-noco to Acquire Japanese Electric Vehicle Manufacturer Assemblepoint

GlobeNewswire

8 months ago

noco-noco to Acquire Japanese Electric Vehicle Manufacturer Assemblepoint

Oilprice.com

8 months ago

Indonesia's $20 Billion Leap into Renewable Energy

Thomas Vo Spends US$114k On Nutex Health Stock

Simply Wall St.

8 months ago

Thomas Vo Spends US$114k On Nutex Health Stock

New survey shows majority of U.S. retailers and manufacturers predict strong 2023 holiday season

GlobeNewswire

8 months ago

New survey shows majority of U.S. retailers and manufacturers predict strong 2023 holiday season

Intellinetics Grows Revenues 10% in Q3 2023; 27% Year-to-Date

Business Wire

8 months ago

Intellinetics Grows Revenues 10% in Q3 2023; 27% Year-to-Date

J.W. Mays' (NASDAQ:MAYS) investors will be pleased with their favorable 90% return over the last three years

Simply Wall St.

8 months ago

J.W. Mays' (NASDAQ:MAYS) investors will be pleased with their favorable 90% return over the last three years

ATA Creativity Global Reports 2023 Third Quarter Financial Results

GlobeNewswire

8 months ago

ATA Creativity Global Reports 2023 Third Quarter Financial Results

eHealth, Inc. (NASDAQ:EHTH) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

eHealth, Inc. (NASDAQ:EHTH) Q3 2023 Earnings Call Transcript

Milestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference Call

GlobeNewswire

9 months ago

Milestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference Call

Wilhelmina International, Inc. Reports Results for Third Quarter 2023

GlobeNewswire

9 months ago

Wilhelmina International, Inc. Reports Results for Third Quarter 2023

Intellinetics to Showcase Payables Automation Solution at Constellation HomeBuilder Systems’ Build Smarter 2023 Conference

Business Wire

9 months ago

Intellinetics to Showcase Payables Automation Solution at Constellation HomeBuilder Systems’ Build Smarter 2023 Conference

Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire

9 months ago

Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Wilhelmina International (NASDAQ:WHLM) Is Looking To Continue Growing Its Returns On Capital

Simply Wall St.

9 months ago

Wilhelmina International (NASDAQ:WHLM) Is Looking To Continue Growing Its Returns On Capital

Trinseo PLC (NYSE:TSE) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Trinseo PLC (NYSE:TSE) Q3 2023 Earnings Call Transcript

Inspirato Announces Third Quarter Results

GlobeNewswire

9 months ago

Inspirato Announces Third Quarter Results

ATA Creativity Global Schedules 2023 Third Quarter Financial Results Release and Conference Call

GlobeNewswire

9 months ago

ATA Creativity Global Schedules 2023 Third Quarter Financial Results Release and Conference Call

Candel Therapeutics Announces Initial Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer

GlobeNewswire

9 months ago

Candel Therapeutics Announces Initial Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer

Share on Social Networks: